Pricing Log in Create free account

SCYNEXIS, Inc. (SCYX) vs Zhengye Biotechnology Holding Limited (ZYBT)

SCYNEXIS, Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Zhengye Biotechnology Holding Limited is the larger, with a market value of $41.0M against $32.8M — 1.2× the size. Across the 9 metrics below, Zhengye Biotechnology Holding Limited leads on 6 and SCYNEXIS, Inc. on 3.

Valuation

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
P/E n/m — 20.55
P/S 1.91 — 2.08
P/B 0.59 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.54 n/m 2.87
Earnings yield (62.76%) — (15.94%)
Free cash flow yield (33.85%) 0.00% 0.00%

Profitability

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Gross margin 100.00% — 53.51%
Operating margin (109.90%) — 0.00%
Net margin (49.74%) — (2.45%)
Free cash flow margin (64.67%) 0.00% 0.00%
Return on equity (18.38%) 0.00% (0.80%)
Return on assets (15.09%) 0.00% (1.67%)
Return on invested capital (110.72%) 0.00% 0.00%

Growth

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 682.47% — 5.22%
EPS growth (last fiscal year) 61.36% (800.00%) 42.91%
Revenue growth, 5-year CAGR 179.40% — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.24 0.04
Current ratio 9.65 1.14 2.41
Net debt to EBITDA 2.54 (0.51) 1.01

Dividend

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric SCYX ZYBT Drug Manufacturers Specialty & Generic median
Market cap 32.84m 41.02m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack